As of 2025-07-14, the EV/EBITDA ratio of Surface Oncology Inc (SURF) is -0.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SURF's latest enterprise value is 50.24 mil USD. SURF's TTM EBITDA according to its financial statements is -80.52 mil USD. Dividing these 2 quantities gives us the above SURF EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 8.7x | 8.5x |
| Forward P/E multiples | 10.3x - 12.2x | 11.7x |
| Fair Price | (13.34) - (11.33) | (13.13) |
| Upside | -1346.5% - -1158.5% | -1326.7% |
| Date | EV/EBITDA |